Literature DB >> 18343896

Role of diet and fuel overabundance in the development and progression of heart failure.

David J Chess1, William C Stanley.   

Abstract

Under physiological conditions, the human heart derives energy from glucose, fatty acids, and/or lactate depending upon substrate availability, circulating hormone levels, and nutritional status. Circulating free fatty acid and glucose levels often exceed the normal range, as observed with type 2 diabetes, obesity, or physical inactivity. Chronic exposure of the heart to high plasma levels of free fatty acids may cause accumulation of toxic lipid intermediates within cardiomyocytes. Furthermore, suppression of glucose oxidation by increased fatty acid uptake shunts glucose into the oxidative pentose phosphate and hexosamine biosynthetic pathways, both of which yield potentially harmful products. Noxious derivatives of aberrant glucose and fatty acid oxidation can activate signalling cascades leading to myocyte dysfunction or death, processes termed 'glucotoxicity' and 'lipotoxicity'. This review discusses the effects of dietary extremes (e.g. high fat and high carbohydrate consumption) and substrate overabundance in the context of heart failure (HF) development and progression. Emerging data suggest that substrate excess leads to cardiac dysfunction and HF, which may be prevented or slowed by maintaining low body fat and high insulin sensitivity and consuming a diet of low glycaemic load that is high in mono- and polyunsaturated fatty acids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343896     DOI: 10.1093/cvr/cvn074

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  70 in total

1.  High-sugar intake does not exacerbate metabolic abnormalities or cardiac dysfunction in genetic cardiomyopathy.

Authors:  Peter A Hecker; Tatiana F Galvao; Karen M O'Shea; Bethany H Brown; Reney Henderson; Heather Riggle; Sachin A Gupte; William C Stanley
Journal:  Nutrition       Date:  2012-02-02       Impact factor: 4.008

Review 2.  Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.

Authors:  Lakshmi Pulakat; Vincent G DeMarco; Sivakumar Ardhanari; Anand Chockalingam; Rukhsana Gul; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

Review 3.  Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD).

Authors:  T F Lang
Journal:  J Inherit Metab Dis       Date:  2009-10-11       Impact factor: 4.982

Review 4.  Evidence for distinct effects of exercise in different cardiac hypertrophic disorders.

Authors:  Emily J Johnson; Brad P Dieter; Susan A Marsh
Journal:  Life Sci       Date:  2015-01-26       Impact factor: 5.037

5.  Sequestration of fatty acids in triglycerides prevents endoplasmic reticulum stress in an in vitro model of cardiomyocyte lipotoxicity.

Authors:  Madeleen Bosma; Dianne H Dapito; Zoi Drosatos-Tampakaki; Ni Huiping-Son; Li-Shin Huang; Sander Kersten; Konstantinos Drosatos; Ira J Goldberg
Journal:  Biochim Biophys Acta       Date:  2014-12

6.  Of mice (dogs) and men: getting to the heart of obesity-associated cardiac dysfunction.

Authors:  Christopher M Haggerty; Linyuan Jing; Brandon K Fornwalt
Journal:  Diabetologia       Date:  2015-10-30       Impact factor: 10.122

Review 7.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

8.  Linoleate-rich high-fat diet decreases mortality in hypertensive heart failure rats compared with lard and low-fat diets.

Authors:  Adam J Chicco; Genevieve C Sparagna; Sylvia A McCune; Christopher A Johnson; Robert C Murphy; David A Bolden; Meredith L Rees; Ryan T Gardner; Russell L Moore
Journal:  Hypertension       Date:  2008-07-28       Impact factor: 10.190

Review 9.  Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Authors:  Carmen Mingorance; Rosalía Rodríguez-Rodríguez; María Luisa Justo; María Alvarez de Sotomayor; María Dolores Herrera
Journal:  Vasc Health Risk Manag       Date:  2011-03-28

10.  Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation.

Authors:  Emil D Bartels; Jan M Nielsen; Lars I Hellgren; Thorkil Ploug; Lars B Nielsen
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.